RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population

Abbott Medical Devices5,379 enrolled

Overview

The purpose of this registry is to produce a prospective, outcome-oriented registry to document the prevalence of AT/AF in the CRM population by using the Advanced AT/AF Diagnostics in select SJM devices.

Study Type

OBSERVATIONAL

Enrollment

5,379

Conditions

Atrial Fibrillation

Interventions

CRM DeviceDEVICE

Pacemaker, ICD, or CRT device

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient is implanted with a CRM device * Patient has no documented history of AF (3 months prior to enrollment) * Patient is \>18 years of age * Patient has life expectancy of \>24 months

Locations (1)

St Jude Medical

Sylmar, California, United States

Outcomes

Primary Outcomes

Prevalence of atrial tachycardia and atrial fibrillation in a cardiac rhythm management population

Time frame: 24 months

Secondary Outcomes

Development or exacerbation of HF

Time frame: 2 years

Development of AF

Time frame: 2 years

AT/AF burden

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.